The Carlyle Group Inc. (CG)
NASDAQ: CG · Real-Time Price · USD
49.86
-1.80 (-3.48%)
At close: Feb 21, 2025, 4:00 PM
49.85
-0.01 (-0.02%)
After-hours: Feb 21, 2025, 5:12 PM EST
The Carlyle Group Revenue
In the year 2024, The Carlyle Group had annual revenue of $4.74B with 95.78% growth. The Carlyle Group had revenue of $876.80M in the quarter ending December 31, 2024, with 13.37% growth.
Revenue (ttm)
$4.74B
Revenue Growth
+95.78%
P/S Ratio
3.77
Revenue / Employee
$2,154,500
Employees
2,200
Market Cap
17.83B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.74B | 2.32B | 95.78% |
| Dec 31, 2023 | 2.42B | -1.70B | -41.19% |
| Dec 31, 2022 | 4.12B | -4.37B | -51.51% |
| Dec 31, 2021 | 8.49B | 5.81B | 217.15% |
| Dec 31, 2020 | 2.68B | -486.00M | -15.36% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Berkshire Hathaway | 369.89B |
| JPMorgan Chase & Co. | 166.78B |
| Bank of America | 96.07B |
| Wells Fargo & Company | 77.96B |
| Morgan Stanley | 61.50B |
| HSBC Holdings | 61.25B |
| American Express Company | 60.76B |
| The Goldman Sachs Group | 52.16B |
CG News
- 5 hours ago - Big 4 Private Equity Firms In Brighter Mood; Falling Investment In Biotech - Seeking Alpha
- 17 hours ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of bluebird bio, Inc. - PRNewsWire
- 23 hours ago - bluebird bio Stock Alert - Kehoe Law Firm, P.C. Investigating the Fairness and Adequacy of the Proposed Acquisition of bluebird bio by Investment Firms in Collaboration with Biotech Execs - Accesswire
- 1 day ago - Bluebird bio to be taken private by Carlyle and SK Capital amid cash crunch - Reuters
- 1 day ago - bluebird bio Announces Definitive Agreement to be Acquired by Carlyle and SK Capital - Business Wire
- 1 day ago - Higher Fee Revenues, Brighter Outlook Boost Mood Of Private Equity's Big 4 - Seeking Alpha
- 1 day ago - Acentra Health Employees Provide Over 3,000 Hours of Volunteer Work to Promote Healthier Communities - GlobeNewsWire
- 2 days ago - The Search For 7% Investment Grade Yields, Part 2: Carlyle And Its Baby Bond - Seeking Alpha